Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification
BCYC Stock | USD 12.61 0.27 2.10% |
About 62% of Bicycle Therapeutics' investor base is looking to short. The analysis of overall sentiment of trading Bicycle Therapeutics stock suggests that many investors are alarmed at this time. The current market sentiment, together with Bicycle Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Bicycle Therapeutics stock news signals to limit their universe of possible portfolio assets.
Bicycle |
Bicycle Therapeutics plc , a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary b
Read at businesswire.com
![]() |
Bicycle Therapeutics Fundamental Analysis
We analyze Bicycle Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bicycle Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bicycle Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Bicycle Therapeutics is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Bicycle Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bicycle Therapeutics stock to make a market-neutral strategy. Peer analysis of Bicycle Therapeutics could also be used in its relative valuation, which is a method of valuing Bicycle Therapeutics by comparing valuation metrics with similar companies.
Peers
Bicycle Therapeutics Related Equities
KROS | Keros Therapeutics | 3.50 | ||||
SEER | Seer | 2.19 | ||||
MGTX | MeiraGTx Holdings | 1.61 | ||||
ORIC | Oric Pharmaceuticals | 1.21 | ||||
GLUE | Monte Rosa | 0.58 | ||||
CGEM | Cullinan Oncology | 0.49 | ||||
STOK | Stoke Therapeutics | 0.31 | ||||
ANAB | AnaptysBio | 0.12 | ||||
MRUS | Merus BV | 0.29 | ||||
ADAG | Adagene | 1.66 | ||||
ANEB | Anebulo Pharmaceuticals | 1.91 | ||||
CCCC | C4 Therapeutics | 1.92 | ||||
MLYS | Mineralys Therapeutics, | 2.05 | ||||
TNYA | Tenaya Therapeutics | 3.85 | ||||
INBX | Inhibrx | 4.50 | ||||
IDYA | Ideaya Biosciences | 4.54 | ||||
IGMS | IGM Biosciences | 5.06 | ||||
ACRV | Acrivon Therapeutics, | 6.60 |
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data |